查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1428181

2024 年臨床前影像全球市場報告

Preclinical Imaging Global Market Report 2024
出版日期: 按訂單生產 | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

臨床前成像市場規模預計在未來幾年將顯著成長。預計到 2028 年將以 6.5% 的複合年成長率 (CAGR) 成長至 44.2 億美元。未來的成長預計將由個人化醫療的採用、分子成像的進步、藥物開發外包的增加、監管支持和慢性病的擴大所推動。預測期內的顯著趨勢包括環保成像技術的出現、技術改進、研發活動激增、合作、夥伴關係和即時成像。

慢性病的預期激增預計將成為臨床前影像市場成長的關鍵驅動力。慢性病的特徵是持續超過 3 個月的長期健康狀況，需要持續的醫療管理，並且可能對個人的生活品質產生重大影響。臨床前影像工具透過可視化骨結構和肺功能在識別這些疾病方面發揮關鍵作用。此外，它還有助於慢性病研究、可視化疾病進展並提高整體理解。例如，根據世界衛生組織（WHO）2022年9月的資料顯示，全球74%的死亡是由非傳染性疾病（NCD）或慢性病引起的，每年死亡人數達到4100萬人。 。值得注意的是，其中包括 1,790 萬人因心血管疾病、930 萬人因癌症、410 萬人因慢性呼吸道疾病和 200 萬人因糖尿病。因此，慢性病盛行率的增加正在推動臨床前影像市場的成長。

藥品需求的成長預計將推動臨床前成像市場的擴張。含有用於預防、診斷或治療疾病的物質的藥品極大地受益於製藥業的臨床前影像。這種影像技術可以在進行臨床試驗之前提供藥物功效、安全性和作用機制的寶貴見解，從而增強決策能力。例如，歐盟統計局 2023 年 4 月報告稱，2022 年藥品和醫藥產品出口與前一年同期比較增 22%，達到 3,070 億美元（2,870 億歐元）。同時，藥品進口額從2021年的1,070億美元（1,000億歐元）增加到2022年的1,200億美元（1,120億歐元）。此外，德國製藥公司默克集團於 2023 年 2 月報告稱，其 2021 年藥品銷售額有所成長。 2022年銷售額達593億美元，較2021年全年成長22%。因此，對藥品的需求不斷成長已成為臨床前成像市場成長的主要驅動力。

目錄

第1章執行摘要

第2章 市場特點

第3章 市場趨勢與策略

第4章宏觀經濟情景

  • 高通膨對市場的影響
  • 烏克蘭與俄羅斯戰爭對市場的影響
  • COVID-19 對市場的影響

第5章世界市場規模與成長

  • 全球臨床前影像市場驅動與阻礙因素
    • 市場驅動力
    • 市場限制
  • 2018-2023年全球臨床前影像市場規模表現與成長
  • 2023-2028、2033年全球臨床前影像市場規模及成長預測

第6章市場區隔

  • 全球臨床前影像市場，按模式細分、實際和預測，2018-2023、2023-2028、2033
  • 光學成像系統
  • 臨床前核子造影系統
  • 微磁振造影系統
  • 微超音波系統
  • 微電腦掃描系統
  • 臨床前光聲成像系統
  • 臨床前磁粒子成像 (MPI) 系統
  • 全球臨床前成像市場，按試劑細分、性能和預測，2018-2023、2023-2028、2033
  • 臨床前光學成像試劑
  • 臨床前核子造影試劑
  • 臨床前MRI顯影劑
  • 臨床前超音波顯影劑
  • 臨床前CT顯影劑
  • 全球臨床前影像市場，按最終用戶細分，實際和預測，2018-2023、2023-2028、2033
  • 醫院
  • 診斷中心
  • 其他最終用戶

第 7 章 區域與國家分析

  • 全球臨床前影像市場，按地區、績效和預測，2018-2023、2023-2028、2033
  • 全球臨床前影像市場，依國家、表現及預測，2018-2023、2023-2028、2033

第8章亞太市場

第9章 中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章 義大利市場

第20章 西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章加拿大市場

第26章 南美洲市場

第27章 巴西市場

第28章 中東市場

第29章 非洲市場

第30章 競爭形勢及公司概況

  • 臨床前影像市場的競爭形勢
  • 臨床前影像市場公司概況
    • Thermo Fisher Scientific Inc.
    • FUJIFILM Visualsonics Inc.
    • Konica Minolta Inc.
    • Agilent Technologies Inc.
    • PerkinElmer Inc.

第31章 其他大型創新公司

  • Bio-Rad Laboratories Inc.
  • Bruker Corporation
  • Miltenyi Biotech
  • Sofie Biosciences Inc.
  • Promega Corporation
  • Ion Beam Applications SA
  • Nihon Kohden
  • EKF Diagnostics Holdings plc.
  • Piramal Enterprises Ltd
  • LI-COR Biosciences Inc.
  • Aspect Imaging Ltd
  • Capintec Inc.
  • Spectral Instruments Inc.
  • Mediso Ltd
  • MR Solutions Ltd

第32章競爭基準化分析

第 33 章. 競爭對手儀表板

第34章 重大併購

第35章 未來前景與可能性分析

第36章附錄

簡介目錄
Product Code: r14025

Preclinical imaging encompasses the utilization of various techniques to observe and analyze biological processes within animal models, preceding their application in human clinical trials. These imaging methods enable researchers to monitor disease progression, assess the effectiveness and safety of potential treatments, and acquire deeper insights into the underlying biological mechanisms of diseases.

Key modalities employed in preclinical imaging include optical imaging systems, preclinical nuclear imaging systems, micro-magnetic resonance imaging systems, micro-ultrasound systems, micro-computed tomography systems, preclinical photoacoustic imaging systems, and preclinical magnetic particle imaging (MPI) systems. Optical imaging systems involve technologies that leverage light to visualize and capture images of biological tissues, cells, or molecules. They are utilized during the preclinical stage for research purposes, disease diagnosis, monitoring tumor blood vessel growth, and tracking tissue blood oxygenation in animals. This encompasses a spectrum of reagents such as preclinical optical imaging reagents, preclinical nuclear imaging reagents, preclinical MRI contrast agents, preclinical ultrasound contrast agents, and preclinical CT contrast agents. Hospitals, diagnostic centers, and other entities form the primary user base for these technologies.

The preclinical imaging market research report is one of a series of new reports from The Business Research Company that provides preclinical imaging market statistics, including preclinical imaging industry global market size, regional shares, competitors with a preclinical imaging market share, detailed preclinical imaging market segments, market trends and opportunities, and any further data you may need to thrive in the preclinical imaging industry. This preclinical imaging market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The preclinical imaging market size has grown strongly in recent years. It will grow from $3.2 billion in 2023 to $3.44 billion in 2024 at a compound annual growth rate (CAGR) of 7.4%. The growth observed in the historical period can be accredited to governmental initiatives, the rise in disease prevalence, expanding applications, heightened awareness, and the expansion of emerging markets.

The preclinical imaging market size is expected to see strong growth in the next few years. It will grow to $4.42 billion in 2028 at a compound annual growth rate (CAGR) of 6.5%. Anticipated growth in the upcoming period is attributable to the adoption of personalized medicine, advancements in molecular imaging, increased outsourcing of drug development, support from regulatory bodies, and the escalation of chronic diseases. Notable trends in the forecast period encompass eco-friendly imaging technologies, technological enhancements, an upsurge in research and development activities, collaborations, partnerships, and the emergence of real-time imaging.

The anticipated surge in chronic diseases is poised to be a significant driver of growth in the preclinical imaging market. Chronic diseases, characterized by prolonged health conditions lasting three months or more, necessitate ongoing medical management and can substantially impact individuals' quality of life. Preclinical imaging tools play a crucial role in identifying these diseases by visualizing bone structure and lung function. Moreover, they contribute to studying chronic diseases, enabling the visualization of disease progression and enhancing overall understanding. For instance, data from the World Health Organization (WHO) 2022 Highlights in September 2022 revealed that 74% of global deaths are caused by Noncommunicable diseases (NCDs) or chronic diseases, amounting to 41 million deaths annually. Notably, this includes 17.9 million deaths from cardiovascular diseases, 9.3 million from cancer, 4.1 million from chronic respiratory diseases, and 2.0 million from diabetes. Thus, the increasing prevalence of chronic diseases is a driving force behind the growth of the preclinical imaging market.

The growing demand for pharmaceutical products is set to propel the expansion of the preclinical imaging market. Pharmaceutical products, encompassing substances formulated to prevent, diagnose, or treat medical conditions, benefit significantly from preclinical imaging in the pharmaceutical industry. This imaging technology enhances decision-making by providing valuable insights into drug efficacy, safety, and mechanisms of action before progressing to clinical trials. For instance, Eurostat reported in April 2023 that exports of medicinal and pharmaceutical products increased to $307 billion (€287 billion) in 2022, reflecting a 22% rise from the previous year. Concurrently, pharmaceutical product imports increased from $107 billion (€100 billion) in 2021 to $120 billion (€112 billion) in 2022. Furthermore, the Merck Group, a Germany-based pharmaceutical company, reported in February 2023 that pharmaceutical product sales for the year 2022 reached $59.3 billion, marking a 22% increase over the full year 2021. Consequently, the heightened demand for pharmaceutical products emerges as a key driver for the growth of the preclinical imaging market.

Product innovation stands out as a prominent trend gaining traction in the preclinical imaging market, with major companies actively engaged in developing cutting-edge products to maintain their market positions. A notable example is Fujifilm VisualSonics Inc., a Canada-based biomedical company specializing in imaging systems, which introduced Vevo F2 for preclinical imaging in May 2022. Distinguished as the first preclinical ultra-high- to low-frequency (71 MHz-1 MHz) ultrasonic and photoacoustic imaging system, Vevo F2 incorporates HD image processing technology and a novel signal pathway. These features contribute to enhanced image clarity, improved frame rates, and customization options tailored to precision imaging demands. With a broad scope of anatomical targets and high-resolution imaging capabilities, Vevo F2 is well-suited for diverse research applications.

Major players in the preclinical imaging market are intensifying their focus on introducing next-generation imaging systems, positioning themselves strategically to gain a competitive advantage. Next-generation imaging systems represent advanced technologies that surpass current capabilities, integrating cutting-edge features. In a significant development, Revvity Inc., a US-based biotechnology company, launched next-generation imaging systems in September 2023, aimed at driving innovation in various preclinical research applications. The product lineup includes the next-generation IVIS Spectrum 2 and IVIS SpectrumCT 2 imaging systems, the Quantum GX3 microCT imaging solution, and a system seamlessly integrating 2D optical and full 3D imaging. These imaging systems boast enhanced image-based capabilities and are designed to streamline the imaging workflow, marking a significant stride in advancing preclinical imaging technologies.

In August 2021, Rigaku Corporation, a Japanese company specializing in X-ray technology, completed the acquisition of MILabs B.V. The deal's financial details remained undisclosed. This strategic move by Rigaku Corporation is targeted at broadening its footprint within the life sciences sector. The acquisition is poised to reinforce the company's research and development capacities concerning its product range while leveraging MILabs' technological advancements and specialized knowledge. MILabs B.V., based in the Netherlands, is known for producing preclinical imaging systems catering to universities, biomedical research, and pharmaceutical studies.

Major companies operating in the preclinical imaging market report are Thermo Fisher Scientific Inc., FUJIFILM Visualsonics Inc., Konica Minolta Inc., Agilent Technologies Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., Bruker Corporation, Miltenyi Biotech, Sofie Biosciences Inc., Promega Corporation, Ion Beam Applications S.A, Nihon Kohden, EKF Diagnostics Holdings plc., Piramal Enterprises Ltd, LI-COR Biosciences Inc., Aspect Imaging Ltd, Capintec Inc., Spectral Instruments Inc., Mediso Ltd, MR Solutions Ltd, Biospace Lab S. A., Scintica Instrumentation Inc., Trifoil Imaging, Bioscan Inc., CytoSMART Technologies B.V, Inviscan SAS, Kubtec X-ray, MILabs B.V., SCANCO Medical AG, Cristal Therapeutics.

North America was the largest region in the preclinical imaging market in 2023. The regions covered in the preclinical imaging market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the preclinical imaging market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The preclinical imaging market includes of revenues earned by entities by providing preclinical imaging services such as magnetic resonance imaging, positron emission tomography, computed tomography, and optical imaging services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Preclinical Imaging Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on preclinical imaging market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for preclinical imaging ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The preclinical imaging market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Modality: Optical Imaging Systems; Preclinical Nuclear Imaging Systems; Micro-magnetic Resonance Imaging Systems; Micro-Ultrasound Systems; Micro-computed Tomography Systems; Preclinical Photoacoustic Imaging Systems; Preclinical Magnetic Particle Imaging (MPI) Systems
  • 2) By Reagents: Preclinical Optical Imaging Reagents; Preclinical Nuclear Imaging Reagents; Preclinical MRI Contrast Agents; Preclinical Ultrasound Contrast Agents; Preclinical CT Contrast Agents
  • 3) By End User: Hospital; Diagnostics Center; Other End-User
  • Companies Mentioned: Thermo Fisher Scientific Inc.; FUJIFILM Visualsonics Inc.; Konica Minolta Inc.; Agilent Technologies Inc.; PerkinElmer Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Preclinical Imaging Market Characteristics

3. Preclinical Imaging Market Trends And Strategies

4. Preclinical Imaging Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Preclinical Imaging Market Size and Growth

  • 5.1. Global Preclinical Imaging Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Preclinical Imaging Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Preclinical Imaging Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Preclinical Imaging Market Segmentation

  • 6.1. Global Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Optical Imaging Systems
  • Preclinical Nuclear Imaging Systems
  • Micro-magnetic Resonance Imaging Systems
  • Micro-Ultrasound Systems
  • Micro-computed Tomography Systems
  • Preclinical Photoacoustic Imaging Systems
  • Preclinical Magnetic Particle Imaging (MPI) Systems
  • 6.2. Global Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Preclinical Optical Imaging Reagents
  • Preclinical Nuclear Imaging Reagents
  • Preclinical MRI Contrast Agents
  • Preclinical Ultrasound Contrast Agents
  • Preclinical CT Contrast Agents
  • 6.3. Global Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospital
  • Diagnostics Center
  • Other End-User

7. Preclinical Imaging Market Regional And Country Analysis

  • 7.1. Global Preclinical Imaging Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Preclinical Imaging Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Preclinical Imaging Market

  • 8.1. Asia-Pacific Preclinical Imaging Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Preclinical Imaging Market

  • 9.1. China Preclinical Imaging Market Overview
  • 9.2. China Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Preclinical Imaging Market

  • 10.1. India Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Preclinical Imaging Market

  • 11.1. Japan Preclinical Imaging Market Overview
  • 11.2. Japan Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Preclinical Imaging Market

  • 12.1. Australia Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Preclinical Imaging Market

  • 13.1. Indonesia Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Preclinical Imaging Market

  • 14.1. South Korea Preclinical Imaging Market Overview
  • 14.2. South Korea Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Preclinical Imaging Market

  • 15.1. Western Europe Preclinical Imaging Market Overview
  • 15.2. Western Europe Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Preclinical Imaging Market

  • 16.1. UK Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Preclinical Imaging Market

  • 17.1. Germany Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Preclinical Imaging Market

  • 18.1. France Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Preclinical Imaging Market

  • 19.1. Italy Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Preclinical Imaging Market

  • 20.1. Spain Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Preclinical Imaging Market

  • 21.1. Eastern Europe Preclinical Imaging Market Overview
  • 21.2. Eastern Europe Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Preclinical Imaging Market

  • 22.1. Russia Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Preclinical Imaging Market

  • 23.1. North America Preclinical Imaging Market Overview
  • 23.2. North America Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Preclinical Imaging Market

  • 24.1. USA Preclinical Imaging Market Overview
  • 24.2. USA Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Preclinical Imaging Market

  • 25.1. Canada Preclinical Imaging Market Overview
  • 25.2. Canada Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Preclinical Imaging Market

  • 26.1. South America Preclinical Imaging Market Overview
  • 26.2. South America Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Preclinical Imaging Market

  • 27.1. Brazil Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Preclinical Imaging Market

  • 28.1. Middle East Preclinical Imaging Market Overview
  • 28.2. Middle East Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Preclinical Imaging Market

  • 29.1. Africa Preclinical Imaging Market Overview
  • 29.2. Africa Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Preclinical Imaging Market Competitive Landscape And Company Profiles

  • 30.1. Preclinical Imaging Market Competitive Landscape
  • 30.2. Preclinical Imaging Market Company Profiles
    • 30.2.1. Thermo Fisher Scientific Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. FUJIFILM Visualsonics Inc.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Konica Minolta Inc.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Agilent Technologies Inc.
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. PerkinElmer Inc.
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Preclinical Imaging Market Other Major And Innovative Companies

  • 31.1. Bio-Rad Laboratories Inc.
  • 31.2. Bruker Corporation
  • 31.3. Miltenyi Biotech
  • 31.4. Sofie Biosciences Inc.
  • 31.5. Promega Corporation
  • 31.6. Ion Beam Applications S.A
  • 31.7. Nihon Kohden
  • 31.8. EKF Diagnostics Holdings plc.
  • 31.9. Piramal Enterprises Ltd
  • 31.10. LI-COR Biosciences Inc.
  • 31.11. Aspect Imaging Ltd
  • 31.12. Capintec Inc.
  • 31.13. Spectral Instruments Inc.
  • 31.14. Mediso Ltd
  • 31.15. MR Solutions Ltd

32. Global Preclinical Imaging Market Competitive Benchmarking

33. Global Preclinical Imaging Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Preclinical Imaging Market

35. Preclinical Imaging Market Future Outlook and Potential Analysis

  • 35.1 Preclinical Imaging Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Preclinical Imaging Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Preclinical Imaging Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer